Parker Entrup

ORCID: 0000-0002-4550-6537
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Opioid Use Disorder Treatment
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Substance Abuse Treatment and Outcomes
  • Migration, Health and Trauma
  • Poisoning and overdose treatments
  • Pain Management and Placebo Effect
  • Musculoskeletal pain and rehabilitation
  • Maternal Mental Health During Pregnancy and Postpartum
  • Social and Intergroup Psychology
  • Traumatic Ocular and Foreign Body Injuries
  • COVID-19 and Mental Health
  • Health, psychology, and well-being
  • Neurotransmitter Receptor Influence on Behavior
  • Prenatal Substance Exposure Effects
  • Interpreting and Communication in Healthcare
  • Gun Ownership and Violence Research
  • Pain Mechanisms and Treatments
  • Maternal and fetal healthcare
  • Cultural Competency in Health Care
  • Alcoholism and Thiamine Deficiency
  • COVID-19 and healthcare impacts
  • Biochemical effects in animals
  • Eating Disorders and Behaviors
  • Cardiac Arrest and Resuscitation
  • Racial and Ethnic Identity Research

The Ohio State University
2022-2024

University of Michigan
2024

The Ohio State University Wexner Medical Center
2023-2024

VA Ann Arbor Healthcare System
2024

In Brief Fibromyalgia and opioid use disorder (OUD) are highly impactful chronic illnesses with substantially overlapping psychosocial, biological, clinical features. Little previous research has examined interactions between fibromyalgia OUD. Limiting such been the requirement of a examination to diagnose fibromyalgia. The 2011 American College Rheumatology Survey (ACR-FMS) is validated self-report instrument high sensitivity specificity for intended enable in settings where impractical....

10.1097/j.pain.0000000000002878 article EN cc-by-nc-nd Pain 2023-03-14

Background: Discovery of modifiable factors influencing subjective withdrawal experience might advance opioid use disorder (OUD) research and precision treatment. This study explores one factor – catastrophizing a negative cognitive emotional orientation toward characterized by excessive fear, worry or inability to divert attention from symptoms.

10.1080/00952990.2023.2298257 article EN cc-by-nc The American Journal of Drug and Alcohol Abuse 2024-03-19

Heavy chronic alcohol use may produce pain amplification through neurochemical and neuroplastic changes at multiple levels of the nervous system. Similar are thought to underlie nociplastic pain. The American College Rheumatology Fibromyalgia Survey has been used as a surrogate for pain, including among individuals with disorder (AUD). However, studies linking pain-motivated drinking lacking. present study aimed determine if is associated in AUD. To achieve this aim, new scale-the...

10.1016/j.jpain.2024.01.332 article EN cc-by Journal of Pain 2024-01-13

Background Central sensitization is an important mechanism underlying many chronic pain conditions. Chronic and alcohol use disorder (AUD) are highly comorbid. Despite great scientific interest in brain mechanisms linking AUD, progress has been impeded by difficulty assessing central AUD.

10.1080/10550887.2023.2237396 article EN cc-by-nc-nd Journal of Addictive Diseases 2023-07-22

In 2020 COVID-19 was the third leading cause of death in United States. Increases suicides, overdoses, and alcohol related deaths were seen-which make up despair. How despair compare to across racial, ethnic, gender subpopulations is relatively unknown. Preliminary studies showed inequalities mortality for Black Hispanic Americans pandemic's onset. This study analyzes ethnic disparities years life lost due (suicide, overdose, deaths) 2020.This cross-sectional calculated compared (YLL) Deaths...

10.1186/s12939-023-01949-9 article EN cc-by International Journal for Equity in Health 2023-08-23

Background: Withdrawal is believed to play a central role in the brain disease model of addiction. However, little research describes withdrawal-motives among untreated individuals community settings. Methods: This cross-sectional study surveyed syringe exchange program participants (n = 139) with opioid use disorder (OUD) Columbus, Ohio from January 10th March 25th, 2023, assess their perceptions withdrawal OUD maintenance, treatment delay, and OUD's refractoriness buprenorphine....

10.1080/10826084.2023.2269571 article EN cc-by-nc-nd Substance Use & Misuse 2023-10-20

The present study aims to compare Years of Life Lost for unintentional drug overdose and the leading underlying causes death in United States annually from 2017 2019. provide valuable context incident deaths when comparing relative mortality burden death. Prior research has shown was third cause state Ohio 2017. However, this finding yet be replicated at national level US. Death statistics 2017–2019 were accessed via CDC WONDER. calculated each top five US during period. Unintentional caused...

10.1080/10550887.2023.2173929 article EN cc-by-nc-nd Journal of Addictive Diseases 2023-03-06

Federico E. Vaca, MD, MPH; James Dziura, PhD; Fuad Abujarad, Michael Pantalon, Allen Hsiao, MD; Jesse Reynolds, MS; Kaitlin R. Maciejewski, Craig A. Field, Gail D'Onofrio, MD

10.1001/jamanetworkopen.2023.14860 article EN cc-by-nc-nd JAMA Network Open 2023-05-23

This cross-sectional study examines years of life lost among the top 3 causes death and compares firearm suicide with other methods individuals aged 10 to 24 in US.

10.1001/jamapediatrics.2023.3366 article EN JAMA Pediatrics 2023-09-05

Background Previous research has found chronic pain to be prevalent among individuals with opioid use disorder (OUD). The perception that is related OUD onset, maintenance, relapse, and treatment delay been noted in this population. However, prior works primarily involved treatment-engaged populations. Scant describes such perceptions non-treatment-seeking individuals.

10.1080/24740527.2024.2332198 article EN cc-by Canadian Journal of Pain 2024-03-20

This cross-sectional study explores health-related quality of life (HRQoL) and the challenges to physical, emotional, social functioning among individuals with opioid use disorder.

10.1001/jamanetworkopen.2024.5968 article EN cc-by-nc-nd JAMA Network Open 2024-04-05

Background/Objectives Chronic pain is an opioid use disorder (OUD) treatment barrier and associated with poor outcomes in OUD including relapse. Fibromyalgia a chronic condition related to central nervous system substrates that overlap the brain disease model of OUD. We know no studies have looked at non-treatment seeking individuals, see if fibromyalgia might represent treatment. Given many non-treatment-seeking individuals previously attempted recovery before experiencing relapse, known...

10.1080/07853890.2024.2422050 article EN cc-by Annals of Medicine 2024-11-05

Background Racial discrimination is associated with health disparities among Black Americans, a group that has experienced an increase in rates of fatal drug overdose. Prior research found racial the medical setting may be barrier to addiction treatment. Nevertheless, it unknown how experiences might impact engagement emergency services for accidental This study will psychometrically assess new measure hesitancy seeking overdose and examine prior group-based mistrust as potential corollaries...

10.1080/07853890.2024.2439540 article EN cc-by-nc Annals of Medicine 2024-12-19
Coming Soon ...